Posted By Dr. Mercola | November 02 2010 | 100,730 views
Diane Murphy, MD, is the Director of the FDA’s Office of Pediatric Therapeutics (OPT). The mission of OPT is to enforce a Congressional mandate that assures access for children to innovative, safe and effective medical products.
Historically, many medical products have not been tested for use in children, leading to an increase in adverse events and the use of ineffective products.
Murphy notes that young children and neonates require the development of a new directional endpoint that can better help us to not treat children with our best guess, but with knowledge.
Dr. Mercola’s Comments
It’s now been fifteen years since Merck’s chickenpox vaccine was approved for market.
What had always been regarded as a relatively benign childhood illness was suddenly reinvented in the 1990s as a life-threatening disease for which children must get vaccinated or face dire health consequences.
But wait—Merck to the rescue!
As is true with many new and potentially unnecessary medical interventions used on a widespread basis, there are often unintended consequences. The chickenpox (varicella) vaccine is a perfect example.
By trying to prevent all children from experiencing chickenpox naturally, this policy may have actually created a NEW epidemic—not in children but in adults, especially elderly adults.
Vaccinating children for chickenpox may very well be causing a shingles epidemic.
Chickenpox—Another False Epidemic
Before the live virus chickenpox vaccine was licensed in the United States in 1995, most children acquired a natural, long-lasting immunity to chickenpox by age six. For 99.9 percent of healthy children, chickenpox is a mild disease without complications.
It is estimated there were about 3.7 million cases of chickenpox annually in the U.S. before 1995, resulting in an average of 100 deaths (50 children and 50 adults, most of whom were immunocompromised). This hardly represents a dire, life-threatening epidemic that requires mass vaccination of all children!